Urigen Pharmaceuticals 305 East High Street Suite 7 Bound Brook, NJ 08805 United States ph: 732-369-5911
Urigen Pharmaceuticals Announces Private Offering to Current Shareholders
CEO Dan Vickery Interviewed about Urigen's clinical program for treating IC/BPS at 2019 Bio CEO Conference
Urigen Series D Financing Investors Qualify for NJ Angel Investor Tax Credit Program